Stemline Therapeutics (STML) Files $50M IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Equities rebound to close higher as surging Treasury yields recede
- Fed’s Jefferson sees no urgency for another rate increase
- Oil jumps 4% on reports China halts fuel exports, US troops head to Middle East
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Anthropic targets mid-November for public debut - report
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Equities rebound to close higher as surging Treasury yields recede
Stemline Therapeutics (STML) Sees IPO Price of $10 - $12/Share
October 22, 2012 6:00 PM EDTStemline Therapeutics (Nasdaq: STML) filed an amended registration with the U.S. SEC for an Initial Public Offering of its Common Stock. The company plans to sell 1,819,000 shares and sees an offering price of $10 to $12 per share. The company plans to list on the... More
